Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma
- PMID: 28980211
- PMCID: PMC6039188
- DOI: 10.1245/s10434-017-6098-6
Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma
Abstract
Background: The prognostic impact of pathologic response to preoperative therapy on patients with duodenal adenocarcinoma (DA) and ampullary adenocarcinoma (AMPA) has not been established.
Methods: A retrospective review of 266 patients who underwent curative resection for DA (n = 97) or AMPA (n = 169) during 1993-2015 was performed. For patients who underwent preoperative therapy, the pathologic response was systematically evaluated and classified as major (0-49% of viable residual tumor cells) or minor (≥ 50% of viable residual tumor cells). Uni- and multivariable analyses were performed to identify predictors of pathologic response and disease-specific survival (DSS).
Results: For the 79 patients treated with preoperative therapy (DA: n = 34; AMPA: n = 45), concomitant use of radiation (80%, 67/79) was the sole independent predictor of major pathologic response (odds ratio [OR] 8.17; 95% confidence interval [CI] 1.85-58.2; P = 0.005). The patients with major pathologic response had a better 5-year DSS rate than the patients with minor pathologic response (DA: 65 vs 25%; P = 0.028; AMPA: 85 vs 43%; P = 0.016). In the multivariable analysis of DSS for the 79 patients who underwent preoperative therapy, major pathologic response was the sole predictor of improved DSS (hazard ratio [HR] 2.88; 95% CI 1.41-5.98; P = 0.004). In the multivariable analysis of DSS for the entire cohort, pathologic stage 2 or lower was the sole predictor of better DSS.
Conclusion: The major pathologic response to preoperative therapy predicted improved DSS after resection of DA and AMPA and might represent a new prognosticator after resection of DA and AMPA.
Conflict of interest statement
Figures
Similar articles
-
Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater.Ann Surg Oncol. 2017 Jul;24(7):2031-2039. doi: 10.1245/s10434-017-5777-7. Epub 2017 Jan 25. Ann Surg Oncol. 2017. PMID: 28124275
-
Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.J Surg Oncol. 2014 May;109(6):556-60. doi: 10.1002/jso.23529. Epub 2013 Dec 11. J Surg Oncol. 2014. PMID: 24338561
-
Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.J Surg Oncol. 2014 Aug;110(2):156-62. doi: 10.1002/jso.23600. Epub 2014 Mar 12. J Surg Oncol. 2014. PMID: 24619853
-
Ampullary and periampullary adenocarcinoma: new challenges in management of recurrence.JOP. 2013 Mar 10;14(2):158-60. doi: 10.6092/1590-8577/1471. JOP. 2013. PMID: 23474562 Review.
-
Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater.J Hepatobiliary Pancreat Surg. 1998;5(3):251-4. doi: 10.1007/s005340050042. J Hepatobiliary Pancreat Surg. 1998. PMID: 9880771 Review.
Cited by
-
Preoperative Misdiagnosis in Patients Undergoing Pancreatoduodenectomy.J Clin Med. 2022 Dec 3;11(23):7200. doi: 10.3390/jcm11237200. J Clin Med. 2022. PMID: 36498774 Free PMC article.
-
Neoadjuvant Therapy for Duodenal and Ampullary Adenocarcinoma: A Systematic Review.Ann Surg Oncol. 2024 Feb;31(2):792-803. doi: 10.1245/s10434-023-14531-y. Epub 2023 Nov 11. Ann Surg Oncol. 2024. PMID: 37952021
-
Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles.J Clin Med. 2020 Dec 30;10(1):104. doi: 10.3390/jcm10010104. J Clin Med. 2020. PMID: 33396821 Free PMC article. Review.
References
-
- Bourgouin S, Ewald J, Mancini J, et al. Predictors of survival in ampullary, bile duct and duodenal cancers following pancreaticoduodenectomy: a 10-year multicentre analysis. J Gastrointest Surg. 2015;19:1247–1255. - PubMed
-
- Berberat PO, Künzli BM, Gulbinas A, et al. An audit of outcomes of a series of periampullary carcinomas. Eur J Surg Oncol. 2009;35:187–191. - PubMed
-
- Shaib WL, Sharma R, Brutcher E, et al. Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma. J Surg Oncol. 2014;109:556–560. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical